- Stocks
- Healthcare
- NYSE: BMY

Price (delayed)

$60.76

Market cap

$136.95B

P/E Ratio

N/A

Dividend/share

$1.8

EPS

-$0.28

Enterprise value

$163.69B

The company's revenue rose by 46% YoY and by 12% QoQ

Bristol Myers Squibb's gross profit has increased by 44% YoY and by 15% from the previous quarter

The net income has dropped by 159% since the previous quarter and by 109% year-on-year

Bristol Myers Squibb's EPS has shrunk by 144% QoQ and by 107% YoY

What are the main financial stats of BMY

Market
Valuations
Earnings

Shares outstanding

2.25B

Market cap

$136.95B

Enterprise value

$163.69B

Price to earnings (P/E)

N/A

Price to book (P/B)

2.8

Price to sales (P/S)

3.94

EV/EBIT

64.96

EV/EBITDA

18.26

EV/Sales

4.7

Revenue

$34.86B

EBIT

$2.52B

EBITDA

$8.96B

Free cash flow

$12B

Per share
Balance sheet
Liquidity

EPS

-$0.28

Free cash flow per share

$5.3

Book value per share

$21.7

Revenue per share

$15.41

TBVPS

$21.36

Total assets

$128.08B

Total liabilities

$78.92B

Debt

$46.67B

Equity

$49.09B

Working capital

$10.92B

Debt to equity

0.95

Current ratio

1.47

Quick ratio

1.26

Net debt/EBITDA

2.98

Margins
Efficiency
Dividend

EBITDA margin

25.7%

Gross margin

69.6%

Net margin

-1.6%

Operating margin

7.3%

Return on assets

-0.5%

Return on equity

-1.3%

Return on invested capital

5%

Return on capital employed

2.4%

Return on sales

7.2%

Dividend yield

2.96%

DPS

$1.8

Payout ratio

N/A

How has the Bristol Myers Squibb stock price performed over time

How have Bristol Myers Squibb's revenue and profit performed over time

Revenue

$34.86B

Gross profit

$24.26B

Operating income

$2.54B

Net income

-$563M

Gross margin

69.6%

Net margin

-1.6%

The net income has dropped by 159% since the previous quarter and by 109% year-on-year

BMY's net margin has dropped by 152% since the previous quarter and by 106% year-on-year

The operating margin has dropped by 77% year-on-year and by 16% since the previous quarter

The operating income has dropped by 66% year-on-year and by 6% since the previous quarter

What is Bristol Myers Squibb's growth rate over time

What is Bristol Myers Squibb stock price valuation

P/E

N/A

P/B

2.8

P/S

3.94

EV/EBIT

64.96

EV/EBITDA

18.26

EV/Sales

4.7

Bristol Myers Squibb's EPS has shrunk by 144% QoQ and by 107% YoY

BMY's P/B is 53% below its 5-year quarterly average of 6.0 and 7% below its last 4 quarters average of 3.0

The company's revenue rose by 46% YoY and by 12% QoQ

The price to sales (P/S) is 16% less than the 5-year quarterly average of 4.7 but 3.7% more than the last 4 quarters average of 3.8

How efficient is Bristol Myers Squibb business performance

Bristol Myers Squibb's ROA has plunged by 150% from the previous quarter and by 103% YoY

The ROE has plunged by 146% from the previous quarter and by 103% YoY

BMY's return on invested capital has dropped by 85% year-on-year and by 14% since the previous quarter

Bristol Myers Squibb's return on sales has shrunk by 77% YoY and by 16% QoQ

What is BMY's dividend history

DPS

$1.8

Dividend yield

2.96%

Payout ratio

N/A

Recent dividends

How did Bristol Myers Squibb financials performed over time

BMY's total assets is 62% greater than its total liabilities

The quick ratio has shrunk by 65% YoY and by 9% QoQ

Bristol Myers Squibb's current ratio has plunged by 62% YoY and by 11% from the previous quarter

BMY's debt is 4.9% smaller than its equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.